Abiopharma

🔍 CRAWFORD STEPHEN GLENN (Executive)

Company: EASTMAN CHEMICAL CO (EMN)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 34,193 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 34,193.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to serve one share of issue common stock.
• F2: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the thirteenth month anniversary of the grant date, February 2, 2027, subject to continued employment.